StockData
TNONNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as TNONW

Tenon Medical, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$2.45−0.25 (-9.26%)

Close on Oct 19, 2026

Market cap
$804
P/E (TTM)
–
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q2 FY2026
Ended Jun 30, 2026
Aug 13, 2026After market close$1.30M$-12.35–
Q1 FY2026
Ended Mar 31, 2026
May 12, 2026After market close$1.40M$-0.31–
Q4 FY2025
Ended Dec 31, 2025
Feb 6, 2026After market close–––
Q4 FY2023
Ended Dec 31, 2023
Mar 14, 2024During market hours–––
Q1 FY2022
Ended Mar 31, 2022
Jun 7, 2022After market close–––

Company guidance

Outlook given with results on Feb 6, 2026, compared with the previous outlook

MeasurePeriodGuidancevs. prior
RevenueFull Year 2025$3.91M to $3.94MNew
RevenueFourth Quarter 2025$1.45M to $1.48MNew

Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.

Press releases

Announcements Tenon Medical filed with the SEC